MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation

EP300-ZNF384-positive B cell acute lymphoblastic leukemia (B-ALL) patients are reported to have a unique immunophenotype with high expression of CD19 and CD22, weak expression of CD20 and aberrant expression of CD13 and/or CD33, sensitivity to chemotherapy and a favorable outcome. To date, the cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin-Yue, Dai, Hai-Ping, Zhang, Ling, Liu, Si-Ning, Dai, Yin, Wu, De-Pei, Tang, Xiao-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565984/
https://www.ncbi.nlm.nih.gov/pubmed/34744437
http://dx.doi.org/10.2147/OTT.S324765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565984/
https://www.ncbi.nlm.nih.gov/pubmed/34744437
http://dx.doi.org/10.2147/OTT.S324765

Ejemplares similares